-
-
Finance -
Finance -
Pharma & Human Health -
Pharma & Human Health
Editor’s Choice
Editor's Choice
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by […]
Editor's Choice
Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
In the past 10 years, there has been significant interest in new classes of active pharmaceutical ingredients (APIs). These novel APIs include live biotherapeutics, which are used for microbiome targeting drugs, oral biologics like GLP1 […]
Editor's Choice
EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
With Expert’Biome™, Lallemand Health Solutions aims to support partners in their development of next-generation strains by offering comprehensive services in the health industry. These services include strains research and development, bioprocesses scaling, drug manufacturing, and […]
In Case you Missed it:
Uncategorized
Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select
Delivering live biotherapeutics orally remains one of the challenges in microbiome therapy. In this white paper, Evonik presents a real-world case study of how EUDRACAP® Select—a ready-to-fill enteric capsule—enabled the safe and targeted delivery of […]
Pharma & Human Health
Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome
Hundreds of new viruses living inside bacteria within our gut have been discovered in an international study led by Professor Jeremy J. Barr from Monash University’s School of Biological Sciences and Associate Professor Sam Forster […]
Animal Health
Phagos Raises €25m Series A
Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology […]
Pharma & Human Health
New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event
A pioneering research network to unlock the link between gut, immune and brain health has taken its first steps at a launch event on September 22 in Southampton. Researchers and stakeholders from across the UK […]
Pharma & Human Health
EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region
The development of novel oral therapeutics—such as live biotherapeutics, peptides, proteins, and nucleotides—has introduced new challenges in drug formulation and delivery. In this article, we describe Evonik’s solution – EUDRACAP® colon – a ready-to-fill, functional […]
Pharma & Human Health
Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing
Recent studies suggest that the steady rise in life expectancy observed over the past 200 years has now stagnated. Data indicate that a limit has been reached, and that medical and healthcare advances no longer […]
Pharma & Human Health
Study finds significant health benefits in adolescents with obesity treated with FMT
Eight years ago, 87 obese adolescents took part in a groundbreaking study to see whether fecal transfer (taking ‘good’ gut bacteria from healthy donors and giving them in capsule form to people with a less […]
Pharma & Human Health
Connection among gut fungi, genetics and disease risk in humans identified
A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the fungal component of the human microbiome — known as the mycobiome — and risk of developing chronic […]
